Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1988
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 1
1993 2
2001 1
2002 1
2003 1
2005 1
2006 1
2007 1
2009 1
2011 1
2013 1
2014 1
2018 1
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.
Masetti R, Bertuccio SN, Pession A, Locatelli F. Masetti R, et al. Br J Haematol. 2019 Feb;184(3):337-347. doi: 10.1111/bjh.15725. Epub 2018 Dec 28. Br J Haematol. 2019. PMID: 30592296 Free PMC article. Review.
The scenario of paediatric acute myeloid leukaemia (AML), particularly non-Down syndrome acute megakaryoblastic leukaemia (non-DS-AMKL), has been recently revolutionized by the advent of large-scale, genomic sequencing technologies. ...
The scenario of paediatric acute myeloid leukaemia (AML), particularly non-Down syndrome acute megakaryoblastic leuk
Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases.
Ribeiro RC, Oliveira MS, Fairclough D, Hurwitz C, Mirro J, Behm FG, Head D, Silva ML, Raimondi SC, Crist WM, et al. Ribeiro RC, et al. Leuk Lymphoma. 1993 Jul;10(4-5):299-306. doi: 10.3109/10428199309148552. Leuk Lymphoma. 1993. PMID: 8220128 Review.
In order to characterize the clinical, cytogenetic, and outcome features of childhood acute megakaryoblastic leukemia (AMKL), we reviewed 24 cases; 14 were identified among 150 consecutive newly diagnosed acute myelogenous leukemia (AML) …
In order to characterize the clinical, cytogenetic, and outcome features of childhood acute megakaryoblastic leukemi
Myeloid leukemia in Down syndrome.
Khan I, Malinge S, Crispino J. Khan I, et al. Crit Rev Oncog. 2011;16(1-2):25-36. doi: 10.1615/critrevoncog.v16.i1-2.40. Crit Rev Oncog. 2011. PMID: 22150305 Free PMC article. Review.
Although adults with Down syndrome (DS) show a decreased incidence of cancer compared to individuals without DS, children with DS are at an increased risk of leukemia. Nearly half of these childhood leukemias are classified as acute megakaryoblastic
Although adults with Down syndrome (DS) show a decreased incidence of cancer compared to individuals without DS, children with DS are at an …
The impact of trisomy 21 on foetal haematopoiesis.
Roberts I, O'Connor D, Roy A, Cowan G, Vyas P. Roberts I, et al. Blood Cells Mol Dis. 2013 Dec;51(4):277-81. doi: 10.1016/j.bcmd.2013.07.008. Epub 2013 Aug 7. Blood Cells Mol Dis. 2013. PMID: 23932236 Free PMC article. Review.
The high frequency of a unique neonatal preleukaemic syndrome, transient abnormal myelopoiesis (TAM), and subsequent acute myeloid leukaemia in early childhood in patients with trisomy 21 (Down syndrome) points to a specific role for trisomy 21 in transforming foeta …
The high frequency of a unique neonatal preleukaemic syndrome, transient abnormal myelopoiesis (TAM), and subsequent acute myeloid le …
Trisomy of chromosome 21 in leukemogenesis.
Izraeli S, Rainis L, Hertzberg L, Smooha G, Birger Y. Izraeli S, et al. Blood Cells Mol Dis. 2007 Sep-Oct;39(2):156-9. doi: 10.1016/j.bcmd.2007.04.004. Epub 2007 May 29. Blood Cells Mol Dis. 2007. PMID: 17532652 Free article. Review.
Constitutional trisomy 21 of Down syndrome (DS) is associated with markedly increased risk for childhood leukemia. Thus the oncogenic role of trisomy 21 in the more common sporadic childhood leukemias may be revealed through the investigations of the relative …
Constitutional trisomy 21 of Down syndrome (DS) is associated with markedly increased risk for childhood leukemia. Thus the on …
Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
Xavier AC, Ge Y, Taub JW. Xavier AC, et al. J Mol Diagn. 2009 Sep;11(5):371-80. doi: 10.2353/jmoldx.2009.080132. J Mol Diagn. 2009. PMID: 19710397 Free PMC article. Review.
DS children have a approximately 10- to 20-fold higher risk for developing acute lymphoblastic leukemia and acute myeloid leukemia (AML), as compared with non-DS children, although they do not have a uniformly increased risk of developing solid tumors. …
DS children have a approximately 10- to 20-fold higher risk for developing acute lymphoblastic leukemia and acute myelo …
Tetrasomy 8 as a primary chromosomal abnormality in a child with acute megakaryoblastic leukemia. a case report and review of the literature.
Aktas D, Tuncbilek E, Cetin M, Hicsonmez G. Aktas D, et al. Cancer Genet Cytogenet. 2001 Apr 15;126(2):166-8. doi: 10.1016/s0165-4608(00)00403-9. Cancer Genet Cytogenet. 2001. PMID: 11376811 Review.
In this report, we describe a 14-year-old girl with acute megakaryoblastic leukemia associated with tetrasomy 8 (primary) and trisomy 6, 19 and 20. ...Interestingly, this abnormality has not been previously reported in childhood AML patients....
In this report, we describe a 14-year-old girl with acute megakaryoblastic leukemia associated with tetrasomy 8 (primar …
Down syndrome, drug metabolism and chromosome 21.
Taub JW, Ge Y. Taub JW, et al. Pediatr Blood Cancer. 2005 Jan;44(1):33-9. doi: 10.1002/pbc.20092. Pediatr Blood Cancer. 2005. PMID: 15390307 Review.
It has been recognized that chromosomal abnormalities in childhood leukemia, are linked to both leukemogenesis and segregate patients into prognostic treatment groups. This is best exemplified in cases of children with Down syndrome (DS), who have significantly high …
It has been recognized that chromosomal abnormalities in childhood leukemia, are linked to both leukemogenesis and segregate p …
Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis.
Vyas P, Roberts I. Vyas P, et al. Early Hum Dev. 2006 Dec;82(12):767-73. doi: 10.1016/j.earlhumdev.2006.09.016. Epub 2006 Oct 24. Early Hum Dev. 2006. PMID: 17064858 Review.
Newborns and children with Down Syndrome are predisposed to a range of blood disorders, which include acute lymphoblastic leukaemia and acute megakaryocytic leukaemia (AMKL). Over the last four years there has been considerable progress in our understanding of DS AM …
Newborns and children with Down Syndrome are predisposed to a range of blood disorders, which include acute lymphoblastic leukaemia a …
Skeletal manifestations of pediatric acute megakaryoblastic leukemia.
Athale UH, Kaste SC, Razzouk BI, Rubnitz JE, Ribeiro RC. Athale UH, et al. J Pediatr Hematol Oncol. 2002 Oct;24(7):561-5. doi: 10.1097/00043426-200210000-00014. J Pediatr Hematol Oncol. 2002. PMID: 12368696 Review.
Once considered rare, acute megakaryoblastic leukemia (AMKL) now accounts for about 12% of all cases of de novo acute myeloid leukemia in children. ...Between January 1984 and December 1999, 43 patients were diagnosed with childhood AMKL …
Once considered rare, acute megakaryoblastic leukemia (AMKL) now accounts for about 12% of all cases of de novo acut
15 results